Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$93.87

-1 (-1.05%)

, QSR

Restaurant Brands

$63.51

0.9 (1.44%)

10:04
01/24/19
01/24
10:04
01/24/19
10:04

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) upgraded to Hold from Sell at Berenberg with analyst James Targett saying his analysis showed large brands trend to outperform, particularly in home care, hygiene and parts of personal care and packaged food. 2. Restaurant Brands (QSR) upgraded to Outperform from Market Perform at BMO Capital with analyst Peter Sklar citing the company's announced dividend increase, strong preliminary comparable sales for Q4, and the appointment of an industry "operator" as CEO. 3. Incyte (INCY) upgraded to Buy from Hold at Gabelli and to Outperform from Market Perform at William Blair. 4. Kimberly-Clark (KMB) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying while its initial FY19 EPS guidance of $6.50-6.70 was 2.5% below the prior consensus at the midpoint, he views it as "reasonable." 5. Southern Company (SO) upgraded to Neutral from Sell at Citi with analyst Praful Mehta saying he believes the company's Vogtle site is showing "good progress" following a visit. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PG

Procter & Gamble

$93.87

-1 (-1.05%)

QSR

Restaurant Brands

$63.51

0.9 (1.44%)

INCY

Incyte

$77.11

1.91 (2.54%)

KMB

Kimberly-Clark

$111.44

-0.71 (-0.63%)

SO

Southern Company

$47.44

-0.14 (-0.29%)

  • 14

    Feb

  • 18

    Feb

  • 03

    Mar

  • 24

    May

  • 28

    May

PG Procter & Gamble
$93.87

-1 (-1.05%)

01/24/19
BREN
01/24/19
UPGRADE
BREN
Hold
Procter & Gamble upgraded to Hold from Sell at Berenberg
Berenberg analyst James Targett upgraded Procter & Gamble to Hold after his analysis showed large brands trend to outperform, particularly in home care, hygiene and parts of personal care and packaged food.
01/18/19
JPMS
01/18/19
UPGRADE
Target $129
JPMS
Overweight
Kimberly-Clark upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira upgraded Kimberly-Clark (KMB) to Overweight and raised her price target for the shares to $129 from $108. While the company's sales growth is still facing secular challenges, it has an opportunity to drive "significant operating margin expansion ahead," Teixeira tells investors in a research note. Following two consecutive years of operating margin challenges, the analyst believes Kimberly-Clark's margins can inflect positively in 2019 due to cost savings, price increases and waning input cost inflation. Teixeira's top pick in Household and Personal Care remains Procter & Gamble (PG).
01/24/19
RHCO
01/24/19
NO CHANGE
Target $95
RHCO
Hold
Procter & Gamble price target raised to $95 from $85 at SunTrust
SunTrust analyst William Chappell raised his price target on Procter & Gamble to $95 after its better than expected Q2 results and a raise in its FY19 organic sales growth expectations to 2%-4% from 2%-3%. The analyst is keeping his Hold rating however, stating that while the management is seeing "positive signs out of most of its key categories, much of the outperformance is due to market share momentum". At its current valuation, Chappell believes that the good news for the company are priced in.
01/24/19
STFL
01/24/19
NO CHANGE
Target $95
STFL
Hold
P&G report has positive read-through for Estee Lauder, says Stifel
Stifel analyst Mark Astrachan believes Procter & Gamble's (PG) better than expected Q2 sales growth and raise in full-year sales guidance suggest the 4% organic sales growth rate in the first half of the fiscal year is reasonable for the second half. He raised his price target on P&G shares to $95 from $93 but keeps a Hold rating on the stock, as he anticipates consensus EPS will remain largely unchanged. Discussing read-throughs from the consumer giant's report, Astrachan said he sees the continued strong growth for prestige beauty brand SK-II as favorable for Estee Lauder (EL) and called heightened innovation in laundry something to watch for Church & Dwight (CHD).
QSR Restaurant Brands
$63.51

0.9 (1.44%)

01/24/19
01/24/19
UPGRADE
Target $74

Outperform
Restaurant Brands upgraded to Outperform at BMO Capital on comps, dividend hike
As previously reported, BMO Capital analyst Peter Sklar upgraded Restaurant Brands to Outperform from Market Perform and raised his price target to $74 from $58. The analyst cites the company's announced dividend increase, strong preliminary comparable sales for Q4, and the appointment of an industry "operator" as CEO. Sklar also believes that naming Daniel Schwartz as executive chairman is a positive development, suggesting that Restaurant Brands' prior phase of cost cutting is complete.
01/24/19
UBSW
01/24/19
NO CHANGE
Target $74
UBSW
Buy
Restaurant Brands valuation inexpensive relative to peers, says UBS
UBS analyst Dennis Geiger believes meaningful upside exists for Restaurant Brands, citing the potential for Tim Horton's comp trends to continue to improve and Burger King comps easing while momentum remains strong. Geiger, who said its investors day can act as a catalyst, reiterated his Buy rating and $74 price target on Restaurant Brands.
01/23/19
BMOC
01/23/19
UPGRADE
BMOC
Outperform
Restaurant Brands upgraded to Outperform from Market Perform at BMO Capital
01/11/19
LBOW
01/11/19
NO CHANGE
LBOW
Neutral
McDonald's likely gained share over Burger King in Q4, says Longbow
Longbow analyst Alton Stump said his checks with U.S. Burger King franchisees lead him to estimate North American same-store sales were down 0.5%-1% in Q4, which he notes is better than his prior estimate for a 1.5% decline but below the consensus call for a 0.2% drop. The introduction of the 10 chicken nuggets for $1 deal in mid-October provided a sales lift but irritated franchisees who were not pleased with the margin pressure, added Stump. Based on his franchisee checks for Burger King and McDonald's (MCD), he thinks the latter gained share over the former, and possibly over Wendy's (WEN), in Q4. Stump keeps a Neutral rating on Burger King parent Restaurant Brands (QSR).
INCY Incyte
$77.11

1.91 (2.54%)

01/23/19
GABE
01/23/19
UPGRADE
GABE
Buy
Incyte upgraded to Buy from Hold at Gabelli
01/24/19
01/24/19
UPGRADE
Target $105

Buy
Incyte upgraded to Buy from Hold at Gabelli
As previously reported, Gabelli analyst Jing He upgraded Incyte to Buy with a price target of $105. The analyst cites the company's increasing pipeline value and multiple catalysts expected in 2019, noting the encouraging response rate data of its Pemigatinib program and the blockbuster potential of its fully-owned itacitinib that targets acute naive graft-versus-host disease, or GVHD.
01/24/19
WBLR
01/24/19
UPGRADE
WBLR
Outperform
William Blair upgrades 'ideal' takeout candidate Incyte to Outperform
William Blair analyst Y. Katherine Xu upgraded Incyte to Outperform from Market Perform and raised her fair value estimate for the shares to $100 from $85. Heading into 2019, Incyte is executing on both commercial and research and development fronts to balance driving near-term profitability growth and realizing long-term appreciation from a "resurgent" pipeline, Xu tells investors in a research note. She believes that after two years of disappointing stock performance due to the epacadostat failure and Olumiant "debacle" in the U.S. regulatory process, the rest of the pipeline has finally reached an inflection point. Further, Incyte is an "ideal" takeover candidate for a large pharma looking for a "blockbuster that moves the needle," earnings accretion, and a "healthy and innovative" pipeline, says the analyst.
01/24/19
WBLR
01/24/19
UPGRADE
WBLR
Outperform
Incyte upgraded to Outperform from Market Perform at William Blair
William Blair analyst Y. Katherine Xu upgraded Incyte to Outperform saying the company's pipeline is "finally" moving beyond Epacadostat.
KMB Kimberly-Clark
$111.44

-0.71 (-0.63%)

01/24/19
01/24/19
UPGRADE
Target $113

Equal Weight
Morgan Stanley says Kimberly-Clark guidance reasonable, upgrades to Equal Weight
As previously reported, Morgan Stanley analyst Dara Mohsenian upgraded Kimberly-Clark to Equal Weight from Underweight, stating that while its initial FY19 EPS guidance of $6.50-6.70 was 2.5% below the prior consensus at the midpoint, he views it as "reasonable." After the 2019 EPS consensus declined by about 11% in the last twelve months, he now thinks the worst of the negative EPS revisions look to be over. The analyst also sees the potential for lower pulp prices, at some point, to likely put a floor below the stock. Mohsenian raised his price target on Kimberly-Clark shares to $113 from $107.
01/24/19
MSCO
01/24/19
UPGRADE
MSCO
Equal Weight
Kimberly-Clark upgraded to Equal Weight from Underweight at Morgan Stanley
10/17/18
WELS
10/17/18
NO CHANGE
Target $105
WELS
Market Perform
Kimberly-Clark price target raised to $105 from $97 at Wells Fargo
Wells Fargo analyst Bonnie Herzog raised her price target for Kimberly-Clark to $105 from $97 ahead of quarterly results. The analyst reiterates a Market Perform rating on the shares.
SO Southern Company
$47.44

-0.14 (-0.29%)

10/10/18
BOFA
10/10/18
UPGRADE
BOFA
Neutral
Southern Company upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith upgraded Southern Company to Neutral with a $46 price target following a tour of the Vogtle Plant. The analyst said management was the most confident it recent memory regarding its ability to execute on time and within budget following Septermber's owners vote. Dumoulin-Smith said the April 2021 service date appears within reach following the recent workforce reset.
01/24/19
SBSH
01/24/19
UPGRADE
Target $50
SBSH
Neutral
Citi upgrades Southern Company to Neutral on reduced Vogtle risks
Citi analyst Praful Mehta upgraded Southern Company to Neutral from Sell and raised his price target for the shares to $50 from $45. The analyst believes the company's Vogtle site is showing "good progress" following a visit. Challenges related to earned hours and labor issues are mostly addressed, Mehta tells investors in a research note. He upgrades Southern Company to Neutral saying near-term Vogtle risks are under control.
12/28/18
ARGS
12/28/18
NO CHANGE
ARGS
Hold
Argus raises Southern Company FY18 EPS view after Q3 beat
Argus analyst Jacob Kilstein kept his Hold rating but raised his FY18 EPS view to $3.05 from $3.02 after the company's Q3 earnings beat and raised FY18 guidance last month. The analyst notes that the company is making progress with resolving its plant construction issues and believes that it has a "well-run base of regulated utility assets", adding that its above-average return on equity is "evidence of the success of its gas utility business." Kilstein states however that he prefers to see "stronger, more sustainable earnings growth and the absence of further cost overruns" before considering an upgrade on Southern Company.
01/24/19
SBSH
01/24/19
UPGRADE
SBSH
Neutral
Southern Company upgraded to Neutral from Sell at Citi
Citi analyst Praful Mehta upgraded Southern Company to Neutral citing reduced Vogtle project risks.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.